General

Ocular ExaminationThe Healthcare SystemKnowledge

No CPD Points


In this edition of Advances in Eyecare we hear from four experts about their fields of research as applicable to optometric practice:

  • Dr Deacon Harle and Paddy Gunn discuss the use of selective laser trabeculoplasty as an alternative to topical drug management of glaucoma and ocular hypertension. They clarify what it is, how it is done and who can do it.
  • Dr Shelby Temple describes the latest technique for macular pigment assessment and the implications for its use in community practice eye health screening.
  • Dr Keyur Patel explains the use of intense pulsed light (IPL) treatment for persistent and chronic lid margin disease.

Last published: April 2020

    Learning objectives

    • 1.1.2 Understand the use of selective laser trabeculoplasty as a means of managing POAG and ocular hypertension.

    • 1.1.2 Understand the use of high energy light impulse therapy for management of lid margin disease.

    • 2.5.3 Understand the evidence base relating to pros and cons of laser versus pharmaceutical management of glaucoma so as better be able to advise patients.

    • 3.1.3 Understand the latest clinical techniques for assessing retinal and macular structure related to macular pigment density.

    • 6.1.1 Understand the association between the levels of macular pigment and macular degeneration.

    • 6.1.11 Understand the use of high energy light impulse therapy in the treatment of chronic lid margin disease.

    • 6.1.11 Understand the use of selective laser trabeculoplasty as a means of managing POAG and ocular hypertension.

    • 7.1.1 Understand the current legality of specialist and IP optometrists in developing skills for laser therapy of conditions such as glaucoma, both in the hospital setting and in future in community practice.

      Unit 1 - Selective laser trabeculoplasty for optometrists (~27 mins)